Cancer

A groundbreaking preclinical study has introduced a promising paradigm in the fight against triple-negative breast cancer (TNBC), a notoriously aggressive...

A groundbreaking study from Weill Cornell Medicine and Beth Israel Deaconess Medical Center has identified a gene, FOXJ1, as a...

T cell lymphomas represent a formidable challenge in the realm of oncology. Despite the transformative success of immunotherapy in treating...

In a groundbreaking initiative poised to redefine our understanding of cancer biology, researchers at Scripps Research have embarked on an...

Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have unveiled groundbreaking insights into the role of...

Metastatic gastric cancer remains one of oncology’s most formidable challenges, often delivering devastating prognoses despite decades of research. However, the...

In a groundbreaking advancement for cancer treatment, the Ochsner MD Anderson Cancer Center in New Orleans has announced the introduction...

A paradigm-shifting study led by researchers at The University of Texas MD Anderson Cancer Center reveals a compelling and unexpected...

Breast cancer survivors often face a multitude of challenges as they transition from active treatment to long-term survivorship, and among...

image: Adelaide University cancer researchers Dr Sarah Boyle and Professor Michael Samuel. view more  Credit: Adelaide University A new study led...

A landmark analysis conducted through the Global Burden of Disease (GBD) Study and recently published in The Lancet Oncology reveals...

Researchers at Selçuk University have unveiled compelling new findings that highlight the potential protective role of selenium, an essential micronutrient,...

Cancer immunotherapy has transformed the landscape of oncology, offering groundbreaking approaches to treating malignancies by harnessing the patient’s own immune...

In the relentless pursuit of innovative cancer therapies, the cGAS–STING (cyclic GMP-AMP synthase–stimulator of interferon genes) pathway has emerged as...

In recent years, glucagon-like peptide 1 receptor agonists (GLP1RAs) have emerged as a transformative class of therapeutics for managing type...

In an extraordinary breakthrough that could redefine the future of colorectal cancer treatment, researchers at Baylor University have pioneered a...

March marks a critical period in raising awareness for colorectal cancer, the second most lethal cancer in the United States,...

Chimeric antigen receptor T (CAR T) cell therapy has revolutionized the landscape of leukemia treatment, offering unprecedented opportunities to target...

In a recent development that underscores the complexities and evolving nature of molecular research in osteoporosis, a pivotal article investigating...

In the realm of advanced prostate cancer treatment, a critical area of inquiry has emerged concerning the concurrent administration of...